Journal article
Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy
Molecular genetics and metabolism, Vol.142(4), 108521
08/2024
DOI: 10.1016/j.ymgme.2024.108521
PMCID: PMC11348664
PMID: 38964050
Abstract
Metachromatic leukodystrophy (MLD) is a rare neurodegenerative disorder. Emerging therapies are most effective in the presymptomatic phase, and thus defining this window is critical. We hypothesize that early development delay may precede developmental plateau. With the advent of presymptomatic screening platforms and transformative therapies, it is essential to define the onset of neurologic disease.
The specific ages of gain and loss of developmental milestones were captured from the medical records of individuals affected by MLD. Milestone acquisition was characterized as: on target (obtained before the age limit of 90th percentile plus 2 standard deviations compared to a normative dataset), delayed (obtained after 90th percentile plus 2 standard deviations), or plateau (skills never gained). Regression was defined as the age at which skills were lost. LI-MLD was defined by age at onset before 2.5 years.
Across an international cohort, 351 subjects were included (n = 194 LI-MLD subcohort). The median age at presentation of the LI-MLD cohort was 1.4 years (25th–75th %ile: 1.0–1.5). Within the LI-MLD cohort, 75/194 (39%) had developmental delay (or plateau) prior to MLD clinical presentation. Among the LI-MLD cohort with a minimum of 1.5 years of follow-up (n = 187), 73 (39.0%) subjects never attained independent ambulation. Within LI-MLD + delay subcohort, the median time between first missed milestone target to MLD decline was 0.60 years (maximum distance from delay to onset: 1.9 years).
Early developmental delay precedes regression in a subset of children affected by LI-MLD, defining the onset of neurologic dysfunction earlier than previously appreciated. The use of realworld data prior to diagnosis revealed an early deviation from typical development. Close monitoring for early developmental delay in presymptomatic individuals may help in earlier diagnosis with important consequences for treatment decisions.
Details
- Title: Subtitle
- Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy
- Creators
- Laura Ann Adang - Children's Hospital of PhiladelphiaSamuel Groeschel - University Children's Hospital TübingenChloe Grzyb - University of PittsburghRussell D'Aiello - Children's Hospital of PhiladelphiaFrancesco Gavazzi - Children's Hospital of PhiladelphiaOmar Sherbini - Children's Hospital of PhiladelphiaNowa Bronner - Children's Hospital of PhiladelphiaAkshilkumar Patel - Children's Hospital of PhiladelphiaAriel Vincent - Children's Hospital of PhiladelphiaAnjana Sevagamoorthy - Children's Hospital of PhiladelphiaSylvia Mutua - Children's Hospital of PhiladelphiaKayla Muirhead - Children's Hospital of PhiladelphiaJohanna Schmidt - Children's Hospital of PhiladelphiaAmy Pizzino - Children's Hospital of PhiladelphiaEmily Yu - Children's Hospital of PhiladelphiaDanielle Jin - University of MinnesotaFlorian Eichler - Massachusetts General HospitalJamie L. Fraser - Children's NationalLisa Emrick - Baylor College of MedicineKeith Van Haren - Stanford UniversityJean-Martin Boulanger - Hôpital Charles-Le MoyneMaura Ruzhnikov - Stanford UniversityMichel Sylvain - Université LavalCam-Tu Émilie Nguyen - Centre Hospitalier Universitaire Sainte-JustineAna Potic - University of BelgradeStephanie Keller - Children's Healthcare of AtlantaAli Fatemi - Johns Hopkins UniversityEloise Uebergang - The University of MelbourneMichele Poe - University of PittsburghPouneh Amir Yazdani - McGill University Health CentreJohn Bernat - University of Iowa Hospitals and Clinics, Iowa City, IA, USAKristen Lindstrom - BioMarin Pharmaceutical Inc, Novato, CA, USAJoshua L. Bonkowsky - University of UtahGenevieve Bernard - McGill UniversityChloe A. Stutterd - The University of MelbournePaul Orchard - University of MinnesotaAshish O. Gupta - University of MinnesotaMerete Ljungberg - Copenhagen University HospitalSabine Groenborg - Copenhagen University HospitalAlberto Zambon - San Raffaele Scientific Institute, Division of Neuroscience, Milan, ItalySara Locatelli - San Raffaele Hospital, Paediatric Immunohematology and Unit of Neurology, Milano, Lombardia, ItalyFrancesca Fumagalli - IRCCS Ospedale San RaffaeleSaskia Elguen - University Children's Hospital TübingenChristiane Kehrer - University Children's Hospital TübingenIngeborg Krägeloh-Mann - University Children's Hospital TübingenJustine Shults - Children's Hospital of PhiladelphiaAdeline Vanderver - Children's Hospital of PhiladelphiaMaria L. Escolar - University of Pittsburgh
- Resource Type
- Journal article
- Publication Details
- Molecular genetics and metabolism, Vol.142(4), 108521
- DOI
- 10.1016/j.ymgme.2024.108521
- PMID
- 38964050
- PMCID
- PMC11348664
- NLM abbreviation
- Mol Genet Metab
- ISSN
- 1096-7192
- eISSN
- 1096-7206
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 08/2024
- Academic Unit
- Stead Family Department of Pediatrics; Medical Genetics and Genomics
- Record Identifier
- 9984651259102771
Metrics
17 Record Views